HOUSTON--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM), a global leader in AI-enabled clean energy software and services, will hold a conference call on Wednesday, March 4, 2026, to discuss its financial results for the fourth quarter and full year ending December 31, 2025. The conference call is scheduled to begin at 5:00 p.m. Eastern Time. A press release regarding the results will be issued at approximately 4:05 p.m. Eastern Time. The conference call may be accessed via a live webcast on a listen.
Winter Park, Florida--(Newsfile Corp. - January 26, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its subsidiary Adia Med of Winter Park, LLC, today highlighted key details of its ongoing IRB-approved clinical study for children with Autism Spectrum Disorder (ASD), listed on ClinicalTrials.gov (NCT07304440). The trial ensures every participating child in Phase One or Phase Two receives umbilical cord blood-derived stem cell and exosome treatments (AdiaVita) three times, administered monthly during the initial three-month interventional phase, combined with glutathione in the experimental arm to evaluate potential improvements in ASD symptoms.
The energy storage sector sits at the intersection of renewable energy expansion, grid modernization, and electrification.
Winter Park, Florida--(Newsfile Corp. - January 13, 2026) - ADIA Nutrition Inc. (OTCQB: ADIA), today announced that its subsidiary, Adia Med of Winter Park, LLC., has officially begun the recruitment process for a groundbreaking clinical study evaluating the potential benefits of stem cell therapy in children with Autism Spectrum Disorder (ASD).
Three-Way Collaboration to Bring Innovative Oral Mucosal Stem Cell Therapy with U.S. GMP Manufacturing and Commercialization Infrastructure to Patients Seeking Treatment for Non-healing Diabetic Foot Ulcers and Other Indications PRINCETON, NJ, DAVIE, FL, AND TEL AVIV, ISRAEL / ACCESS Newswire / January 7, 2026 / Cytora Therapeutics Ltd. (Cytora), a clinical-stage biotechnology company based in Israel developing allogeneic, stem cell therapies; Made Scientific, Inc. (Made Scientific), a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO); and Zeo ScientifiX, Inc. (Zeo), a Florida-based clinical-stage biopharmaceutical company specializing in research, clinical trials, manufacturing and the commercialization, and market access of biologics, today announced a comprehensive strategic partnership to advance and commercialize Cytora's novel allogeneic, off- the- shelf, human oral mucosal stem cell therapy in the United States.
Three-Way Collaboration t o Bring Innovative Oral Mucosal Stem Cell Therapy with U.S. GMP Manufacturing and Commercialization Infrastructure to Patients Seeking Treatment for Non-healing Diabetic Foot Ulcers and Other Indications PRINCETON, N.J. and DAVIE, Fla.
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Samsung Electronics Canada Inc. has announced the launch of the 2025/2026 Solve for Tomorrow Contest.
AI data centers are driving a power crisis - and creating a $50-billion opportunity in energy storage, fuel cells, and batteries.
HOUSTON--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM), a global leader reimagining technology to support the energy transition, announced today that it is partnering with a leading clean energy asset owner focused on distributed solar and storage projects to operate and optimize a portfolio of battery energy storage systems (BESS) serving a local water utility company in Southern California. The four-site portfolio, including one hybrid solar and storage system, supports the Southern California wat.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--GE Vernova today announced it has set a new GUINNESS WORLD RECORDS title for the largest online toy drive in 24 hours, marking a milestone in its global giving campaign focused on inspiring curiosity in future innovators through STEM-focused play. On Global Giving Day (Dec. 2), GE Vernova led a global Innovators Toy Drive in partnership with Toys for Tots – collecting over 23,000 toys in 24-hours to set the new world record. As part of its commitment to giving.
